Research on characteristics of the biopharmaceutical pipeline and on changes since 2003 includes a description of new features and recommendations for health policy decision makers.
Paul C. Nagle, BSBA
Advertisement
Articles by Paul C. Nagle, BSBA
Advertisement
Latest Updated Articles
- Characteristics of and Trends in the Late-stage Biopharmaceutical Pipeline
Published: April 15th 2008 | Updated:
- Review of Recent US Cost Estimates of Revascularization
Published: October 1st 2004 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer
2
Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets
3
Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care
4
3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission
5